Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tailoring BRCAPRO to Asian-Americans.

Literature DB >> 19075251

Tailoring BRCAPRO to Asian-Americans.

Sining Chen, Amanda L Blackford, Giovanni Parmigiani.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2008 PMID： 19075251 PMCID： PMC4877690 DOI： 10.1200/JCO.2008.20.6896

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

× No keyword cloud information.

8 in total

1. BayesMendel: an R environment for Mendelian risk prediction.

Authors: Sining Chen; Wenyi Wang; Karl W Broman; Hormuzd A Katki; Giovanni Parmigiani
Journal: Stat Appl Genet Mol Biol Date: 2004-09-17

2. Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients.

Authors: Nan-Yan Rao; Zhen Hu; Jin-Ming Yu; Wen-Feng Li; Bin Zhang; Feng-Xi Su; Jiong Wu; Zhen-Zhou Shen; Wei Huang; Zhi-Ming Shao
Journal: Breast Cancer Res Treat Date: 2008-09-19 Impact factor: 4.872

3. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

Authors: G Parmigiani; D Berry; O Aguilar
Journal: Am J Hum Genet Date: 1998-01 Impact factor: 11.025

Review 4. Understanding mathematical models for breast cancer risk assessment and counseling.

Authors: D M Euhus
Journal: Breast J Date: 2001 Jul-Aug Impact factor: 2.431

5. BRCA1 and BRCA2 mutations in women from Shanghai China.

Authors: Nicola M Suter; Roberta M Ray; Yong Wei Hu; Ming Gang Lin; Peggy Porter; Dao Li Gao; Renata E Zaucha; Lori M Iwasaki; Leah P Sabacan; Mariela C Langlois; David B Thomas; Elaine A Ostrander
Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-02 Impact factor: 4.254

6. Characterization of BRCA1 and BRCA2 mutations in a large United States sample.

Authors: Sining Chen; Edwin S Iversen; Tara Friebel; Dianne Finkelstein; Barbara L Weber; Andrea Eisen; Leif E Peterson; Joellen M Schildkraut; Claudine Isaacs; Beth N Peshkin; Camille Corio; Leoni Leondaridis; Gail Tomlinson; Debra Dutson; Rich Kerber; Christopher I Amos; Louise C Strong; Donald A Berry; David M Euhus; Giovanni Parmigiani
Journal: J Clin Oncol Date: 2006-02-20 Impact factor: 44.544

7. Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program.

Authors: P H Levine; S C Steinhorn; L G Ries; J L Aron
Journal: J Natl Cancer Inst Date: 1985-02 Impact factor: 13.506

8. Performance of BRCA1/2 mutation prediction models in Asian Americans.

Authors: Allison W Kurian; Gail D Gong; Nicolette M Chun; Meredith A Mills; Ashley D Staton; Kerry E Kingham; Beth B Crawford; Robin Lee; Salina Chan; Susan S Donlon; Yolanda Ridge; Karen Panabaker; Dee W West; Alice S Whittemore; James M Ford
Journal: J Clin Oncol Date: 2008-09-08 Impact factor: 44.544

8 in total

9 in total

Tailoring BRCAPRO to Asian-Americans.

1. BayesMendel: an R environment for Mendelian risk prediction.

2. Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients.

3. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

Review 4. Understanding mathematical models for breast cancer risk assessment and counseling.

5. BRCA1 and BRCA2 mutations in women from Shanghai China.

6. Characterization of BRCA1 and BRCA2 mutations in a large United States sample.

7. Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program.

8. Performance of BRCA1/2 mutation prediction models in Asian Americans.

1. Reclassification of predictions for uncovering subgroup specific improvement.

2. Simpson's paradox in the integrated discrimination improvement.

3. A two-stage approach to genetic risk assessment in primary care.

4. The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer cases.

5. Providing access to risk prediction tools via the HL7 XML-formatted risk web service.

6. Recent BRCAPRO upgrades significantly improve calibration.

7. Simplifying clinical use of the genetic risk prediction model BRCAPRO.

Review 8. Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO.

Review 9. Hereditary breast cancer in the Han Chinese population.